We are live on
!
Find out more
EC
EntryPoint Capital Portfolio holdings
AUM
$341M
1-Year Est. Return
20.57%
This Fund
S&P 500
This Quarter
Est. Return
+2.29%
1 Year Est. Return
+20.57%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$112M
AUM Growth
+$7.22M
(+6.9%)
Cap. Flow
+$6.17M
Cap. Flow
% of AUM
5.54%
Top 10 Holdings %
Top 10 Hldgs %
3.56%
Holding
1,843
New
512
Increased
412
Reduced
454
Closed
458
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Unisys
UIS
|
+$562K |
| 2 |
Fulgent Genetics
FLGT
|
+$385K |
| 3 |
Schrodinger
SDGR
|
+$384K |
| 4 |
Agilysys
AGYS
|
+$367K |
| 5 |
Riot Platforms
RIOT
|
+$344K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NextDecade
NEXT
|
+$565K |
| 2 |
American Well
AMWL
|
+$535K |
| 3 |
iHeartMedia
IHRT
|
+$499K |
| 4 |
BRC Group Holdings
RILY
|
+$497K |
| 5 |
Lexicon Pharmaceuticals
LXRX
|
+$496K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.49% |
| 2 | Industrials | 17.12% |
| 3 | Technology | 16.79% |
| 4 | Financials | 12.57% |
| 5 | Consumer Discretionary | 12.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
SL Green Realty
SLG
$3.88B
| $10.6K | 0.01% |
192
+136
| +243% | +$6.44K |
|
|
CVSA
1227
Covista Inc
CVSA
$3.94B
| $10.5K | 0.01% |
+205
| New | +$10.7K |
|
1228
OraSure Technologies
OSUR
$273M
| $10.5K | 0.01% |
1,708
-24,008
| -93% | -$174K |
|
1229
Sweetgreen
SG
$713M
| $10.5K | 0.01% |
+415
| New | +$6.04K |
|
1230
Credit Acceptance
CACC
$6B
| $10.5K | 0.01% |
19
+9
| +90% | +$4.94K |
|
|
BNY
1231
Bank of New York Mellon
BNY
$108B
| $10.4K | 0.01% |
181
-380
| -68% | -$20.9K |
|
1232
Capital One
COF
$124B
| $10.4K | 0.01% |
70
-170
| -71% | -$23K |
|
1233
InterContinental Hotels
IHG
$23B
| $10.4K | 0.01% |
98
+96
| +4,800% | +$9.62K |
|
1234
Pacific Biosciences
PACB
$422M
| $10.2K | 0.01% |
+2,713
| New | +$15.9K |
|
1235
Wells Fargo
WFC
$261B
| $10.1K | 0.01% |
175
+36
| +26% | +$1.88K |
|
1236
Leidos
LDOS
$14.1B
| $9.96K | 0.01% |
76
-603
| -89% | -$71.9K |
|
|
ACLX
1237
DELISTED
Arcellx
ACLX
| $9.88K | 0.01% |
142
-508
| -78% | -$32.2K |
|
1238
Legend Biotech
LEGN
$4.3B
| $9.87K | 0.01% |
+176
| New | +$10.6K |
|
1239
A.O. Smith
AOS
$8.38B
| $9.75K | 0.01% |
109
+12
| +12% | +$990 |
|
|
DAWN
1240
DELISTED
Day One Biopharmaceuticals
DAWN
| $9.62K | 0.01% |
+582
| New | +$8.71K |
|
1241
RELX
RELX
$60.1B
| $9.44K | 0.01% |
218
+162
| +289% | +$6.85K |
|
1242
Fresenius Medical Care
FMS
$13.2B
| $9.41K | 0.01% |
+488
| New | +$9.67K |
|
1243
Kontoor Brands
KTB
$4.62B
| $9.4K | 0.01% |
+156
| New | +$9.34K |
|
1244
Accel Entertainment
ACEL
$979M
| $9.36K | 0.01% |
794
-5,835
| -88% | -$62.2K |
|
1245
Structure Therapeutics
GPCR
$3.49B
| $9.34K | 0.01% |
218
-7,617
| -97% | -$321K |
|
1246
Thermo Fisher Scientific
TMO
$211B
| $9.3K | 0.01% |
+16
| New | +$8.98K |
|
1247
Saratoga Investment
SAR
$309M
| $9.23K | 0.01% |
398
-5,713
| -93% | -$134K |
|
1248
SharkNinja
SN
$21B
| $9.22K | 0.01% |
148
+110
| +289% | +$5.82K |
|
|
SNV
1249
DELISTED
Synovus
SNV
| $9.21K | 0.01% |
230
+12
| +6% | +$451 |
|
1250
Booz Allen Hamilton
BAH
$8.7B
| $9.2K | 0.01% |
62
-690
| -92% | -$97.2K |
|
Similar funds
SFA
FCM
CPI
SW
MTIC
KFSC
YCM
SC
EntryPoint Capital's Q1 2024 Portfolio in Review
As of Q1 2024, EntryPoint Capital held 1,843 positions worth $112M, up 6.9% from $104M the previous quarter. Its ten largest holdings account for 3.6% of the portfolio.
EntryPoint Capital deployed $6.17M of net new capital in Q1 2024, opening 512 new positions and adding to 412 existing holdings. Its largest new stake was Unisys: 92,556 shares worth $454K.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 19% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was NextDecade, an estimated $565K trimmed.
- EntryPoint Capital's largest Q1 2024 buy was Unisys: 92,556 shares worth $454K.
- EntryPoint Capital added most to Fulgent Genetics in Q1 2024, an estimated $385K increase.
- EntryPoint Capital's biggest Q1 2024 reduction was NextDecade, cutting an estimated $565K.
- EntryPoint Capital fully exited American Well in Q1 2024, selling an estimated $535K.
- EntryPoint Capital's ten largest holdings make up 3.6% of its $112M portfolio in Q1 2024.
- EntryPoint Capital opened 512 new positions and closed 458 in Q1 2024.
- EntryPoint Capital's portfolio value rose 6.9% quarter-over-quarter to $112M.
Based on EntryPoint Capital's 13F filing for Q1 2024, filed 14 May 2024.